ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis
Europe - FRA:ACT - DE000A2YNT30 - Common Stock
140 EUR
-1.8 (-1.27%)
Overall ACT gets a fundamental rating of 7 out of 10. We evaluated ACT against 66 industry peers in the Chemicals industry. Both the health and profitability get an excellent rating, making ACT a very profitable company, without any liquidiy or solvency issues. ACT is not valued too expensively and it also shows a decent growth rate. These ratings could make ACT a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
In the past year ACT was profitable.
ACT had a positive operating cash flow in the past year.
ACT had positive earnings in each of the past 5 years.
ACT had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of ACT (10.48%) is better than 93.94% of its industry peers.
ACT has a Return On Equity of 26.66%. This is amongst the best in the industry. ACT outperforms 98.48% of its industry peers.
ACT's Return On Invested Capital of 13.72% is amongst the best of the industry. ACT outperforms 93.94% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ACT is above the industry average of 7.12%.
The last Return On Invested Capital (13.72%) for ACT is above the 3 year average (12.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.48% | ||
| ROE | 26.66% | ||
| ROIC | 13.72% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
1.3 Margins
ACT has a better Profit Margin (10.43%) than 80.30% of its industry peers.
ACT's Profit Margin has improved in the last couple of years.
ACT has a Operating Margin of 15.34%. This is amongst the best in the industry. ACT outperforms 86.36% of its industry peers.
ACT's Operating Margin has improved in the last couple of years.
ACT has a Gross Margin of 65.74%. This is amongst the best in the industry. ACT outperforms 96.97% of its industry peers.
In the last couple of years the Gross Margin of ACT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.34% | ||
| PM (TTM) | 10.43% | ||
| GM | 65.74% |
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ACT is creating value.
The number of shares outstanding for ACT has been reduced compared to 1 year ago.
ACT has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ACT has an improved debt to assets ratio.
2.2 Solvency
ACT has an Altman-Z score of 4.79. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
ACT has a better Altman-Z score (4.79) than 89.39% of its industry peers.
ACT has a debt to FCF ratio of 1.15. This is a very positive value and a sign of high solvency as it would only need 1.15 years to pay back of all of its debts.
ACT's Debt to FCF ratio of 1.15 is amongst the best of the industry. ACT outperforms 95.45% of its industry peers.
ACT has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
ACT has a Debt to Equity ratio of 0.18. This is in the better half of the industry: ACT outperforms 69.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 1.15 | ||
| Altman-Z | 4.79 |
ROIC/WACC1.92
WACC7.16%
2.3 Liquidity
ACT has a Current Ratio of 2.84. This indicates that ACT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.84, ACT belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
A Quick Ratio of 1.73 indicates that ACT should not have too much problems paying its short term obligations.
ACT has a better Quick ratio (1.73) than 77.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.84 | ||
| Quick Ratio | 1.73 |
3. Growth
3.1 Past
ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.65%, which is quite impressive.
ACT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.60% yearly.
Looking at the last year, ACT shows a small growth in Revenue. The Revenue has grown by 1.03% in the last year.
Measured over the past years, ACT shows a quite strong growth in Revenue. The Revenue has been growing by 8.06% on average per year.
EPS 1Y (TTM)25.65%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%10.81%
Revenue 1Y (TTM)1.03%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%4.91%
3.2 Future
The Earnings Per Share is expected to grow by 19.37% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.02% on average over the next years.
EPS Next Y17.45%
EPS Next 2Y16.02%
EPS Next 3Y19.32%
EPS Next 5Y19.37%
Revenue Next Year2.89%
Revenue Next 2Y6.03%
Revenue Next 3Y8.49%
Revenue Next 5Y6.02%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 24.52 indicates a rather expensive valuation of ACT.
ACT's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 25.83. ACT is around the same levels.
A Price/Forward Earnings ratio of 20.42 indicates a rather expensive valuation of ACT.
ACT's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 32.68, ACT is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.52 | ||
| Fwd PE | 20.42 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as ACT.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACT indicates a somewhat cheap valuation: ACT is cheaper than 60.61% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.46 | ||
| EV/EBITDA | 12.79 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ACT has an outstanding profitability rating, which may justify a higher PE ratio.
ACT's earnings are expected to grow with 19.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.41
PEG (5Y)1
EPS Next 2Y16.02%
EPS Next 3Y19.32%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.11%, ACT has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.21, ACT is paying slightly less dividend.
With a Dividend Yield of 1.11, ACT pays less dividend than the S&P500 average, which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.11% |
5.2 History
The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
31.40% of the earnings are spent on dividend by ACT. This is a low number and sustainable payout ratio.
The dividend of ACT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP31.4%
EPS Next 2Y16.02%
EPS Next 3Y19.32%
FRA:ACT (11/7/2025, 7:00:00 PM)
140
-1.8 (-1.27%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners35.95%
Inst Owner ChangeN/A
Ins Owners30.48%
Ins Owner ChangeN/A
Market Cap1.43B
Revenue(TTM)555.53M
Net Income(TTM)57.92M
Analysts81.82
Price Target161.52 (15.37%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.11% |
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP31.4%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)33.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)2.73%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.66%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.52 | ||
| Fwd PE | 20.42 | ||
| P/S | 2.57 | ||
| P/FCF | 34.46 | ||
| P/OCF | 12.66 | ||
| P/B | 6.56 | ||
| P/tB | 6.67 | ||
| EV/EBITDA | 12.79 |
EPS(TTM)5.71
EY4.08%
EPS(NY)6.86
Fwd EY4.9%
FCF(TTM)4.06
FCFY2.9%
OCF(TTM)11.06
OCFY7.9%
SpS54.57
BVpS21.35
TBVpS20.99
PEG (NY)1.41
PEG (5Y)1
Graham Number52.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.48% | ||
| ROE | 26.66% | ||
| ROCE | 19.03% | ||
| ROIC | 13.72% | ||
| ROICexc | 16.02% | ||
| ROICexgc | 16.17% | ||
| OM | 15.34% | ||
| PM (TTM) | 10.43% | ||
| GM | 65.74% | ||
| FCFM | 7.45% |
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexgc growth 3Y25.57%
ROICexgc growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score7
Asset Turnover1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 1.15 | ||
| Debt/EBITDA | 0.36 | ||
| Cap/Depr | 270.53% | ||
| Cap/Sales | 12.82% | ||
| Interest Coverage | 42.05 | ||
| Cash Conversion | 100.91% | ||
| Profit Quality | 71.41% | ||
| Current Ratio | 2.84 | ||
| Quick Ratio | 1.73 | ||
| Altman-Z | 4.79 |
F-Score7
WACC7.16%
ROIC/WACC1.92
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.65%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%10.81%
EPS Next Y17.45%
EPS Next 2Y16.02%
EPS Next 3Y19.32%
EPS Next 5Y19.37%
Revenue 1Y (TTM)1.03%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%4.91%
Revenue Next Year2.89%
Revenue Next 2Y6.03%
Revenue Next 3Y8.49%
Revenue Next 5Y6.02%
EBIT growth 1Y19.3%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year49.4%
EBIT Next 3Y27.83%
EBIT Next 5Y19.11%
FCF growth 1Y37.04%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y113.41%
OCF growth 3Y34.7%
OCF growth 5Y19.23%
ALZCHEM GROUP AG / ACT.DE FAQ
Can you provide the ChartMill fundamental rating for ALZCHEM GROUP AG?
ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE.
What is the valuation status of ALZCHEM GROUP AG (ACT.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to ALZCHEM GROUP AG (ACT.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for ALZCHEM GROUP AG?
ALZCHEM GROUP AG (ACT.DE) has a profitability rating of 9 / 10.
What are the PE and PB ratios of ALZCHEM GROUP AG (ACT.DE) stock?
The Price/Earnings (PE) ratio for ALZCHEM GROUP AG (ACT.DE) is 24.52 and the Price/Book (PB) ratio is 6.56.
What is the financial health of ALZCHEM GROUP AG (ACT.DE) stock?
The financial health rating of ALZCHEM GROUP AG (ACT.DE) is 9 / 10.